BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26666370)

  • 21. Chitosan oligosaccharide as prospective cross-linking agent for naproxen-loaded Ca-alginate microparticles with improved pH sensitivity.
    Čalija B; Milić J; Cekić N; Krajišnik D; Daniels R; Savić S
    Drug Dev Ind Pharm; 2013 Jan; 39(1):77-88. PubMed ID: 22339172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A genetic analysis of nitrosative stress.
    Foster MW; Liu L; Zeng M; Hess DT; Stamler JS
    Biochemistry; 2009 Feb; 48(4):792-9. PubMed ID: 19138101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening of anionic-modified polymers in terms of stability, disintegration, and swelling behavior.
    Laffleur F; Ijaz M; Menzel C
    Drug Dev Ind Pharm; 2017 Nov; 43(11):1866-1872. PubMed ID: 28673094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel pH-sensitive hydrogel composed of N,O-carboxymethyl chitosan and alginate cross-linked by genipin for protein drug delivery.
    Chen SC; Wu YC; Mi FL; Lin YH; Yu LC; Sung HW
    J Control Release; 2004 Apr; 96(2):285-300. PubMed ID: 15081219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In situ gelling xyloglucan/alginate liquid formulation for oral sustained drug delivery to dysphagic patients.
    Itoh K; Tsuruya R; Shimoyama T; Watanabe H; Miyazaki S; D'Emanuele A; Attwood D
    Drug Dev Ind Pharm; 2010 Apr; 36(4):449-55. PubMed ID: 19788404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alginate-based bipolymeric-nanobioceramic composite matrices for sustained drug release.
    Hasnain MS; Nayak AK; Singh M; Tabish M; Ansari MT; Ara TJ
    Int J Biol Macromol; 2016 Feb; 83():71-7. PubMed ID: 26608007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adipic acid dihydrazide treated partially oxidized alginate beads for sustained oral delivery of flurbiprofen.
    Maiti S; Singha K; Ray S; Dey P; Sa B
    Pharm Dev Technol; 2009; 14(5):461-70. PubMed ID: 19235554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Release behaviour of diclofenac sodium dispersed in Gelucire and encapsulated with alginate beads.
    Al-Taani B; Khanfar MS; Salem MS; Sallam A
    J Microencapsul; 2010; 27(1):10-3. PubMed ID: 20078392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics, biocompatibility and bioavailability of a controlled release monoclonal antibody formulation.
    Schweizer D; Vostiar I; Heier A; Serno T; Schoenhammer K; Jahn M; Jones S; Piequet A; Beerli C; Gram H; Goepferich A
    J Control Release; 2013 Dec; 172(3):975-82. PubMed ID: 24140353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generic nitric oxide (NO) generating surface by immobilizing organoselenium species via layer-by-layer assembly.
    Yang J; Welby JL; Meyerhoff ME
    Langmuir; 2008 Sep; 24(18):10265-72. PubMed ID: 18710268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of in situ gelling alginate formulations as a sustained release vehicle for co-precipitates of dextromethrophan and Eudragit S 100.
    El Maghraby GM; Elzayat EM; Alanazi FK
    Acta Pharm; 2014 Mar; 64(1):29-44. PubMed ID: 24670350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nitrosative stress inhibits production of the virulence factor alginate in mucoid Pseudomonas aeruginosa.
    Wood SR; Firoved AM; Ornatowski W; Mai T; Deretic V; Timmins GS
    Free Radic Res; 2007 Feb; 41(2):208-15. PubMed ID: 17364947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral liquid in situ gelling methylcellulose/alginate formulations for sustained drug delivery to dysphagic patients.
    Shimoyama T; Itoh K; Kobayashi M; Miyazaki S; D'Emanuele A; Attwood D
    Drug Dev Ind Pharm; 2012 Aug; 38(8):952-60. PubMed ID: 22283456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In situ cross-linking of sodium alginate with calcium and aluminum ions to sustain the release of theophylline from polymeric matrices.
    Nokhodchi A; Tailor A
    Farmaco; 2004 Dec; 59(12):999-1004. PubMed ID: 15598436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rocket fuel for the quantification of S-nitrosothiols. Highly specific reduction of S-nitrosothiols to thiols by methylhydrazine.
    Wiesweg M; Berchner-Pfannschmidt U; Fandrey J; Petrat F; de Groot H; Kirsch M
    Free Radic Res; 2013 Feb; 47(2):104-15. PubMed ID: 23181469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetics of S-nitrosation of thiols in nitric oxide solutions.
    Keshive M; Singh S; Wishnok JS; Tannenbaum SR; Deen WM
    Chem Res Toxicol; 1996 Sep; 9(6):988-93. PubMed ID: 8870986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The controlled and sustained release of a fungicide from starch and alginate beads.
    Singh B; Sharma DK; Gupta A
    J Environ Sci Health B; 2009 Feb; 44(2):113-22. PubMed ID: 19130369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hollow S-nitrosothiols nanoparticle with polymeric brushes for nitric oxide (NO)-releasing as tumor targeted chemotherapy.
    Wang J; Bi Y; Ruan H; Sun G; Cui X; Yang X; Qin C
    J Biomater Sci Polym Ed; 2019 Feb; 30(2):122-136. PubMed ID: 30522414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design of in situ dispersible and calcium cross-linked alginate pellets as intestinal-specific drug carrier by melt pelletization technique.
    Nurulaini H; Wong TW
    J Pharm Sci; 2011 Jun; 100(6):2248-57. PubMed ID: 21213311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism and kinetics of inducible nitric oxide synthase auto-S-nitrosation and inactivation.
    Smith BC; Fernhoff NB; Marletta MA
    Biochemistry; 2012 Feb; 51(5):1028-40. PubMed ID: 22242685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.